Abstract
Anti-NXP2 antibodies should be tested in patients with dermatomyositis, ILD and idiopathic inflammatory myopathies http://ow.ly/KiEMe
MeSH terms
-
Adenosine Triphosphatases / immunology*
-
Adult
-
Autoantibodies / blood*
-
Autoimmunity*
-
Biomarkers / blood
-
DNA-Binding Proteins / immunology*
-
Dermatomyositis / blood
-
Dermatomyositis / diagnosis
-
Dermatomyositis / drug therapy
-
Dermatomyositis / immunology*
-
Female
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Lung Diseases, Interstitial / blood
-
Lung Diseases, Interstitial / diagnosis
-
Lung Diseases, Interstitial / drug therapy
-
Lung Diseases, Interstitial / immunology*
-
Tomography, X-Ray Computed
-
Treatment Outcome
Substances
-
Autoantibodies
-
Biomarkers
-
DNA-Binding Proteins
-
Immunosuppressive Agents
-
Adenosine Triphosphatases
-
MORC3 protein, human